drugset / Trial / NCT02971605

Persisting Effects of Psilocybin

NCT02971605

NaSingle-groupOpen-labelBasic science

Summary

The proposed pilot study will assess whether ingestion of a classic hallucinogen (psilocybin) leads to changes in emotion processing and neural circuitry that may predict repeated self-administration of this drug and underlie an atypical mechanism of abuse liability, which may vitally contribute to the understanding of the potential for abuse and the underlying mechanisms supporting abuse of classic hallucinogens.

Timeline

Start
2017-07-01
Primary completion
2018-08-21
Completion
2018-08-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Psilocybin Other / unclassified 25 mg

Indications

No indication recorded.